What information and the extent of information to be provided in an informed assent/consent form of pediatric drug trials
Key points Informed assent/consent remains one of the most challenging issues in pediatric drug trials, with no trustworthy clue or guidance to determine what type of information and the extent of information to be provided in an informed assent/consent form. Based on our empirical data, risk–benefi...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | BMC Medical Ethics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12910-022-00856-y |